| Identification | Back Directory | [Name]
(2S)-2,6-diamino-5-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxyhexanoic acid | [CAS]
32448-35-4 | [Synonyms]
Hydroxylysine-glucose-galactose Glucosylgalactosyl hydroxylysine L-Lysine, 5-[(2-O-α-D-glucopyranosyl-β-D-galactopyranosyl)oxy]- L-Lysine, 5-[(2-O-a-D-glucopyranosyl-b-D-galactopyranosyl)oxy]- (9CI) (2S)-2,6-diamino-5-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxyhexanoic acid | [Molecular Formula]
C18H34N2O13 | [MOL File]
32448-35-4.mol | [Molecular Weight]
486.47 |
| Hazard Information | Back Directory | [Uses]
5-[(2-O-A-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-L-lysine is a bone formation and bone resorption marker that is related to bone turnover processes during growth and development as well as metabolic bone diseases; it is also involved with reactions associated with the functional expression of human mannan-binding proteins (MBPs) in human cell lines transfected with MBP cDNA. |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|